RANI THERAPEUTICS HOLD
2.3400
20-September-24 14:59:59
15 minutes delayed
Stocks
+0.0300
+1.30%
Today's range
2.3400 - 2.6000
ISIN
N/A
Source
NASDAQ
-
Rani Therapeutics Announces Termination of Public Offering of Class A Common Stock
11 Aug 2022 22:47:30 By Nasdaq GlobeNewswire
-
Rani Therapeutics Announces Proposed Public Offering of Class A Common Stock
10 Aug 2022 16:28:34 By Nasdaq GlobeNewswire
-
Rani Therapeutics Reports Second Quarter 2022 Financial Results; Provides Corporate Update
10 Aug 2022 15:28:17 By Nasdaq GlobeNewswire
-
Rani Therapeutics Announces Positive Topline Results from Phase 1 Study of RT-102 in Osteoporosis
10 Aug 2022 15:23:29 By Nasdaq GlobeNewswire
-
08 Aug 2022 07:30:00 By Nasdaq GlobeNewswire
-
Rani Therapeutics Reports First Quarter 2022 Financial Results; Provides Corporate Update
11 May 2022 15:05:01 By Nasdaq GlobeNewswire
-
Rani Therapeutics to Present at Upcoming Investor Conferences
03 May 2022 15:05:01 By Nasdaq GlobeNewswire
-
03 May 2022 06:00:02 By Nasdaq GlobeNewswire
-
Rani Therapeutics to Present at the 21st Annual Needham Virtual Healthcare Conference
07 Apr 2022 15:05:00 By Nasdaq GlobeNewswire
-
29 Mar 2022 15:05:00 By Nasdaq GlobeNewswire
-
23 Mar 2022 19:38:02 By Nasdaq GlobeNewswire
-
Rani Therapeutics Announces Initiation of Phase 1 Study of RT-102 Oral PTH for Osteoporosis
23 Mar 2022 07:00:01 By Nasdaq GlobeNewswire
-
23 Feb 2022 07:00:02 By Nasdaq GlobeNewswire
-
Rani Therapeutics Appoints Lisa Rometty to Board of Directors
07 Jan 2022 07:00:01 By Nasdaq GlobeNewswire
-
Rani Therapeutics Reports Third Quarter 2021 Financial Results, Provides Corporate Update
15 Nov 2021 18:31:25 By Nasdaq GlobeNewswire
-
Rani Therapeutics Appoints Lyn Baranowski to Board of Directors
12 Nov 2021 15:05:00 By Nasdaq GlobeNewswire
-
Rani Therapeutics to Participate in a Fireside Chat at the Stifel 2021 Virtual Healthcare Conference
10 Nov 2021 15:05:02 By Nasdaq GlobeNewswire
-
Rani Therapeutics to Present at Cantor Fitzgerald Virtual Global Healthcare Conference
23 Sep 2021 15:05:00 By Nasdaq GlobeNewswire
-
Rani Therapeutics Reports Second Quarter 2021 Financial Results, Provides Corporate Update
13 Sep 2021 15:05:00 By Nasdaq GlobeNewswire
-
Rani Therapeutics Announces Appointment of Eric Groen as General Counsel
09 Sep 2021 07:00:03 By Nasdaq GlobeNewswire